Literature DB >> 21901719

Long-term effects of weight-reducing diets in hypertensive patients.

Andrea Siebenhofer1, Klaus Jeitler, Andrea Berghold, Andreas Waltering, Lars G Hemkens, Thomas Semlitsch, Christoph Pachler, Reinhard Strametz, Karl Horvath.   

Abstract

BACKGROUND: All major guidelines for antihypertensive therapy recommend weight loss. Thus dietary interventions that aim to reduce body weight might be a useful intervention to reduce blood pressure and adverse cardiovascular events associated with hypertension.
OBJECTIVES: Primary objectivesTo assess the long-term effects of weight-reducing diets in hypertensive patients on-   all cause mortality -   cardiovascular morbidity -   adverse events (including total serious adverse events, withdrawal due to adverse events and total non-serious adverse events)Secondary objectivesTo assess the long-term effects of weight-reducing diets in hypertensive patients on-   change from baseline in systolic blood pressure -   change from baseline in diastolic blood pressure -   body weight reduction SEARCH STRATEGY: Studies were obtained from computerised searches of Ovid MEDLINE, EMBASE, CENTRAL and from searches in reference lists and systematic reviews. SELECTION CRITERIA: Randomised controlled trials (RCT) in adult hypertensive patients were included if they had a study duration of at least 24 weeks and compared weight reducing dietary interventions to no dietary intervention in adult patients with primary hypertension. DATA COLLECTION AND ANALYSIS: Two authors independently assessed risk of bias and extracted data. Studies were pooled using fixed-effect meta-analysis. In case of moderate or larger heterogeneity as measured by Higgins I(2), a random effects model was used. MAIN
RESULTS: Eight studies involving a total of 2100 participants with high blood pressure and a mean age of 45 to 66 years met our inclusion criteria. Mean treatment duration was 6 to 36 months. No study included mortality as a pre-defined outcome. One RCT evaluated the effects of dietary weight loss on a combined endpoint, consisting of the necessity of reinstating antihypertensive therapy and severe cardiovascular complications. In this RCT weight reducing diet lowered the endpoint, hazard ratio 0.70 (95% confidence interval [CI], 0.57 to 0.87) compared to no diet. None of the studies evaluated adverse events as designated in our protocol. Blood pressure was reduced in patients assigned to weight loss diets as compared to controls: systolic blood pressure (SBP): weighted mean difference (WMD): -4.5 mm Hg; 95% CI, -7.2 to -1.8 mm Hg (3 of  8  studies included in analysis), and diastolic blood pressure (DBP): WMD -3.2 mm Hg; 95% CI, -4.8 to -1.5 mm Hg (3 of  8  studies included in analysis). Patients' body weight was also reduced in dietary weight loss groups as compared to controls, WMD of -4.0 kg (95% CI: -4.8 to -3.2) (5 of  8  studies included in analysis). Two studies used withdrawal of antihypertensive medication as their primary outcome. Even though this was not considered a relevant outcome for this review, the results of these studies strengthen the finding of reduction of blood pressure by dietary weight loss interventions. AUTHORS'
CONCLUSIONS: In patients with primary hypertension, weight loss diets reduced body weight and blood pressure, however the magnitude of the effects are uncertain as a result of the small number of patients and studies that could be included in the analyses. It is not known whether weight loss reduces mortality and morbidity. No useful information on adverse effects was reported in the relevant trials.

Entities:  

Mesh:

Year:  2011        PMID: 21901719     DOI: 10.1002/14651858.CD008274.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  20 in total

Review 1.  New advances in models and strategies for developing anti-obesity drugs.

Authors:  Gilbert W Kim; Jieru E Lin; Erik S Blomain; Scott A Waldman
Journal:  Expert Opin Drug Discov       Date:  2013-04-29       Impact factor: 6.098

2.  Metabolic syndrome is associated with increased risk of short-term post-procedural complications after carotid artery stenting.

Authors:  Shuyang Dong; Zeyan Peng; Yong Tao; Yinchao Huo; Huadong Zhou
Journal:  Neurol Sci       Date:  2017-08-07       Impact factor: 3.307

Review 3.  Pathogenesis of obstructive sleep apnoea in hypertensive patients: role of fluid retention and nocturnal rostral fluid shift.

Authors:  L H White; T D Bradley; A G Logan
Journal:  J Hum Hypertens       Date:  2014-10-23       Impact factor: 3.012

4.  Obesity is associated with race/sex disparities in diabetes and hypertension prevalence, but not cardiovascular disease, among HIV-infected adults.

Authors:  Amanda L Willig; Andrew O Westfall; E Turner Overton; Michael J Mugavero; Greer A Burkholder; David Kim; Eric Chamot; James L Raper; Heidi M Crane; Michael S Saag; James H Willig
Journal:  AIDS Res Hum Retroviruses       Date:  2015-07-23       Impact factor: 2.205

5.  Treatment for overweight and obesity in adult populations: a systematic review and meta-analysis.

Authors:  Leslea Peirson; James Douketis; Donna Ciliska; Donna Fitzpatrick-Lewis; Muhammad Usman Ali; Parminder Raina
Journal:  CMAJ Open       Date:  2014-10-01

6.  Neuropeptide Y promoter polymorphism modifies effects of a weight-loss diet on 2-year changes of blood pressure: the preventing overweight using novel dietary strategies trial.

Authors:  Xiaomin Zhang; Qibin Qi; Jun Liang; Frank B Hu; Frank M Sacks; Lu Qi
Journal:  Hypertension       Date:  2012-09-10       Impact factor: 10.190

7.  A low-carbohydrate/high-fat diet reduces blood pressure in spontaneously hypertensive rats without deleterious changes in insulin resistance.

Authors:  John D Bosse; Han Yi Lin; Crystal Sloan; Quan-Jiang Zhang; E Dale Abel; Troy J Pereira; Vernon W Dolinsky; J David Symons; Thunder Jalili
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-04-19       Impact factor: 4.733

Review 8.  Long-term effects of weight-reducing diets in people with hypertension.

Authors:  Thomas Semlitsch; Klaus Jeitler; Andrea Berghold; Karl Horvath; Nicole Posch; Stephanie Poggenburg; Andrea Siebenhofer
Journal:  Cochrane Database Syst Rev       Date:  2016-03-02

Review 9.  Increasing physical activity for the treatment of hypertension: a systematic review and meta-analysis.

Authors:  Thomas Semlitsch; Klaus Jeitler; Lars G Hemkens; Karl Horvath; Eva Nagele; Christoph Schuermann; Nicole Pignitter; Kirsten H Herrmann; Siw Waffenschmidt; Andrea Siebenhofer
Journal:  Sports Med       Date:  2013-10       Impact factor: 11.136

Review 10.  Pre-hypertension: rationale for pharmacotherapy.

Authors:  Brent M Egan; Marilyn A Laken
Journal:  Curr Hypertens Rep       Date:  2013-12       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.